Pancreatic Cancer Research

ResearcherSheng Jing HospitalNo recent work listed

Baosheng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0934-1659; OpenAlex author ID A5100612194. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2014: 3 papers · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 3 papers

Papers 10

  1. Aberrant expression of PELI1 caused by Jagged1 accelerates the malignant phenotype of pancreatic cancer. Co-author DOI 10.1016/j.cellsig.2023.110877↗
  2. GID2 Interacts With CDKN3 and Regulates Pancreatic Cancer Growth and Apoptosis. Co-author DOI 10.1016/j.labinv.2023.100122↗
  3. PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression. Co-author DOI 10.1038/s41417-023-00609-y↗
  4. Case report: identification of ERC1-RET fusion in a patient with pancreatic ductal adenocarcinoma. First author DOI 10.21037/gs-21-469↗
  5. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway. Co-author DOI 10.1007/s13105-020-00734-4↗
  6. Expression of Beclin 1 and Bcl-2 in pancreatic neoplasms and its effect on pancreatic ductal adenocarcinoma prognosis. First author DOI 10.3892/ol.2017.7218↗
  7. Long-Term Diabetes Mellitus Is Associated with an Increased Risk of Pancreatic Cancer: A Meta-Analysis. First author DOI 10.1371/journal.pone.0134321↗
  8. Analysis of dysregulation of immune system in pancreatic cancer based on gene expression profile. Co-author DOI 10.1007/s11033-014-3307-2↗
  9. Identification of genes and candidate agents associated with pancreatic cancer. Co-author DOI 10.1007/s13277-013-1009-3↗
  10. Expression of stromal cell-derived factor 1 and CXCR7 ligand receptor system in pancreatic adenocarcinoma. Last author DOI 10.1186/1477-7819-12-348↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiangpeng Meng · 6 shared papers, 2014–2023 · strength 1.07
  2. Wenyang Zhou · 3 shared papers, 2023 · strength 0.68
  3. Jia Ma · 3 shared papers, 2020–2023 · strength 0.56
  4. Jia Ma · 2 shared papers, 2023 · strength 0.46
  5. Shaolong Sun · 4 shared papers, 2014–2017 · strength 0.28
  6. Xin Deng · 1 shared paper, 2023 · strength 0.22
  7. Zhen Liu · 2 shared papers, 2014–2020 · strength 0.21
  8. Xin Wu · 1 shared paper, 2020 · strength 0.15
  9. Shanshan Song · 2 shared papers, 2015–2017 · strength 0.15
  10. Zhen Liu · 2 shared papers, 2014 · strength 0.13
  11. Yi Zhao · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.